Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 50 EP applications Harald Kluschanzoff has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 28, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12007710

Orodispersible film compositions

IPC classification:
A61K 47/44, A61K 31/485, A61K 9/70
Applicant:
Hexal AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12008196

Oral pharmaceutical composition comprising dabigatran etexilate

IPC classification:
A61K 9/16
Applicant:
Hexal AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14187025

Crystalline methyl ester of rosuvastatin

IPC classification:
A61K 31/505, C07D 239/42
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
GRANT OF PATENT INTENDED
EP13191659

Stabilized amorphous lorcaserin hydrochloride

IPC classification:
A61K 31/55, C07D 223/16, A61P 3/04
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP13195067

Synthesis of vortioxetine via (2-(piperazine-1-yl)phenyl)lithium intermediates

IPC classification:
C07D 295/096
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP13196935

Apparatus for simulating the function of human stomach and/or human intestine

IPC classification:
G09B 23/30, F04B 43/12
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14151147

Synthesis of vortioxetine via (2-(piperazine-1-yl)phenyl)aniline intermediates

IPC classification:
A61K 31/495, C07D 295/096, A61P 25/24
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14159828

Synthesis of 2-arylmethyl-5-aryl-thiophene

IPC classification:
C07D 409/10, C07D 333/54, C07D 333/12
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14163774

Synthesis of vortioxetine via (2,4-dimethylphenyl)(2-iodophenyl)sulfane intermediate

IPC classification:
A61K 31/495, C07D 295/096, A61P 25/24
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14165135

Novel crystalline form of 1-(beta-D-glucopyranosyl)-4- methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene

IPC classification:
C07D 409/10
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14168813

Stereoselective synthesis of intermediates in the preparation of ss-C-arylglucosides

IPC classification:
C07F 1/08, C07D 409/10, C07D 407/12, C07D 309/10
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14170338

Processes for the preparation of ss-aminosulfone compounds

IPC classification:
C07C 315/04
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14178989

Novel hydrates of dolutegravir sodium

IPC classification:
A61P 31/18, A61K 31/5365, C07D 498/14
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14721256

PHARMACEUTICAL COMPOSITION CONTAINING CRYSTALLINE MACITENTAN

IPC classification:
A61K 31/506, A61K 9/20
Applicant:
Sandoz AG
Agent:
Ter Meer Steinmeister & Partner PartGmbB
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
EXAMINATION IN PROGRESS
EP14182755

Pharmaceutical compositions comprising Canagliflozin

IPC classification:
A61P 3/10, A61K 31/7042, A61K 9/20, A61K 9/00
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP14724472

TABLET WITH INCREASED DRUG LOAD OF ODANACATIB

IPC classification:
A61K 31/277, A61K 9/20, A61K 9/16
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
EXAMINATION REQUESTED
EP14724113

TABLET WITH INCREASED DRUG LOAD OF ODANACATIB

IPC classification:
A61K 31/277, A61K 9/20, A61K 9/16
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
EXAMINATION REQUESTED
EP14736339

1-[2-(2,4-DIMETHYLPHENYLSULFANYL) PHENYL]PIPERAZINE ACETATE IN CRYSTALLINE FORM

IPC classification:
A61P 25/00, A61K 31/495, C07D 295/096
Applicant:
LEK Pharmaceuticals dd
Agent:
PRÜFER & PARTNER mbB
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
The patent has been granted
EP14198980

NOVEL SOLVATES OF N-[2-[(1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-(METHYLSULFONYL)ETHYL]-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-4-YL]ACETAMIDE

IPC classification:
A61P 35/00, A61K 31/4035, C07D 209/48
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP15151449

Processes for preparing dolutegravir and analogues thereof

IPC classification:
C07D 498/14
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP16157997

MULTI-DOSE DRY POWDER INHALERS

IPC classification:
A61P 11/08, A61P 11/06, A61K 31/167, A61K 9/12, A61K 9/14
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15162960

MODIFIED PARTICLES OF PALBOCICLIB

IPC classification:
A61P 35/00, A61K 31/519, C07D 471/04
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP15172082

A NOVEL SYNTHETIC PATHWAY TOWARDS APREMILAST

IPC classification:
C07F 5/02, C07C 315/04
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP15185823

A SYNTHETIC PATHWAY TOWARDS APREMILAST

IPC classification:
C07C 315/00, C12P 17/10
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP15188651

CRYSTALLINE ENCENICLINE HYDROCHLORIDE

IPC classification:
A61K 31/439, C07D 453/04
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP15189380

AFATINIB-CONTAINING FORMULATION

IPC classification:
A61K 31/517, A61K 9/20, A61K 9/16, A61K 9/14
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP15194610

CRYSTALLINE FORMS OF ENTINOSTAT

IPC classification:
A61K 31/4406, C07D 213/30
Applicant:
Sandoz AG
Agent:
PRÜFER & PARTNER mbB
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP15722530

PHARMACEUTICAL COMPOSITIONS OF EDOXABAN

IPC classification:
A61P 7/02, A61K 9/20, A61K 31/444
Applicant:
Sandoz AG
Agent:
PRÜFER & PARTNER mbB
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
The patent has been granted
EP15201150

CRYSTALLINE OMARIGLIPTIN SALTS

IPC classification:
A61P 3/10, A61K 31/4162, C07D 487/04
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP15202426

PHARMACEUTICAL COMPOSITION OF VORTIOXETINE HYDROBROMIDE COMPRISING AN INERT CORE FORMED OF AN ACIDIC REACTING COMPOUND

IPC classification:
A61K 31/4465, A61K 9/50, A61K 9/16
Applicant:
Hexal AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP15201645

LEVODOPA AND CARBIDOPA MODIFIED RELEASE COMPOSITION

IPC classification:
A61K 31/194, A61K 31/198, A61K 31/195, A61K 45/06, A61K 9/48, A61K 9/16
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
APPLICATION PUBLISHED
EP16150589

A NOVEL SYNTHETIC PATHWAY TOWARDS SOLITHROMYCIN AND PURIFICATION THEREOF

IPC classification:
C07H 1/00, C07H 17/08
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
The application has been published
EP16151562

PHARMACEUTICAL COMPOSITION OF SELEXIPAG

IPC classification:
A61K 9/16
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
The application has been published
EP16166903

HYDROGEN FUMARATE SALT OF 1-[3-[3-(4-CHLOROPHENYL)PROPOXY]PROPYL]PIPERIDINE

IPC classification:
A61P 25/28, A61K 31/4453, C07D 295/088
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
The application has been published
EP16701355

AN APPARATUS AND METHOD FOR PRODUCING A FLOW PROFILE

IPC classification:
A61B 5/087, A61B 5/00, A61M 15/00, A61B 7/00
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
Request for examination was made
EP16704176

PHARMACEUTICAL COMPOSITIONS COMPRISING LEDIPASVIR AND SOFOSBUVIR

IPC classification:
A61K 9/20, A61K 9/14
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
Request for examination was made
EP16180606

PHARMACEUTICAL COMPOSITION COMPRISING IDELALISIB

IPC classification:
A61P 35/02, A61P 19/08, A61K 31/52, A61K 9/20, A61K 47/38, A61K 47/36, A61K 47/18, A61K 47/12, A61K 47/10, A61K 31/517
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
The application has been published
EP16710997

CRYSTALLINE FORMS OF CABOZANTINIB PHOSPHATE AND CABOZANTINIB HYDROCHLORIDE

IPC classification:
A61P 35/00, A61K 31/47, C07D 215/22
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
Request for examination was made
EP16711818

CABOZANTINIB SALTS AND THEIR USE AS ANTI-CANCER AGENTS

IPC classification:
A61P 35/00, A61K 31/47, C07D 215/22
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
Request for examination was made
EP16717596

CRYSTALLINE ELIGLUSTAT HYDROCHLORIDE

IPC classification:
C07D 405/06
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
Request for examination was made
EP16187705

OMEPRAZOLE FORMULATIONS

IPC classification:
A61K 31/00, A61K 9/16
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
The application has been published
EP16203212

SOLID FORMS OF VENETOCLAX

IPC classification:
A61K 9/20, A61P 35/00, A61K 31/496, A61K 31/437, C07D 471/04
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
The application has been published
EP16204720

PHARMACEUTICAL COMPOSITIONS COMPRISING OMARIGLIPTIN

IPC classification:
A61P 3/10, A61K 31/4162, A61K 9/20
Applicant:
Hexal AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
The application has been published
EP16204714

PHARMACEUTICAL COMPOSITION COMPRISING OMARIGLIPTIN

IPC classification:
A61P 3/10, A61K 31/4162, A61K 9/48
Applicant:
Hexal AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
The application has been published
EP16748127

FORM C OF AVIBACTAM SODIUM

IPC classification:
A01N 43/90, C07D 471/04
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
Request for examination was made
EP16750854

SOLID PHARMACEUTICAL COMPOSITION OF ABACAVIR, LAMIVUDINE, AND EFAVIRENZ

IPC classification:
A61K 31/7068, A61K 31/536, A61K 31/52, A61K 9/28, A61K 9/20
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
Request for examination was made
EP16204717

PHARMACEUTICAL COMPOSITION COMPRISING OMARIGLIPTIN

IPC classification:
A61K 31/4162, A61K 9/48, A61K 9/20
Applicant:
Hexal AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
The application has been published
EP16204721

PHARMACEUTICAL COMPOSITION COMPRISING OMARIGLIPTIN

IPC classification:
A61P 3/10, A61K 31/4162, A61K 9/20
Applicant:
Hexal AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
The application has been published
EP16206398

SELECTIVE OXIDATION OF MALTODEXTRIN AND ITS USE IN THE PREPARATION OF WATER-SOLUBLE IRON (III) CARBOXYMALTOSE COMPLEXES

IPC classification:
C08K 3/00, C08B 37/00
Applicant:
LEK Pharmaceuticals dd
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
The application has been published
EP16779109

AFATINIB-CONTAINING FORMULATION

IPC classification:
A61K 31/517, A61K 9/20, A61K 9/16, A61K 9/14
Applicant:
Sandoz AG
Agent:
Harald Kluschanzoff, Sandoz International GmbH
Status:
Request for examination was made

Please Sign in to use this feature